{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-005913","form_type":"8-K","ticker":"CCRN","cik":"0001141103","company_name":"CROSS COUNTRY HEALTHCARE INC","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.505710+00:00","generated_at":"2026-06-05T21:43:00.649009+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cross Country Healthcare Q4 net income drops 77% on 34% revenue decline","bullets":["Q4 2023 revenue $414M, down 34% YoY and 6% sequentially; full year revenue $2.02B, down 28%.","Q4 net income $9.0M (-77% YoY); diluted EPS $0.26 vs $1.05 in Q4 2022.","Q4 adjusted EBITDA $20.6M (-64% YoY); margin 5.0%, down 410 bps YoY.","Q4 cash from ops $12.1M (+179% YoY); full year cash from ops $248.5M (+85% YoY).","Full year adjusted EPS $2.23 vs $5.27 in 2022; net income $72.6M (-61% YoY)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-005913","json":"https://secwatch.observer/filing/0001628280-24-005913.json","markdown":"https://secwatch.observer/filing/0001628280-24-005913.md","text":"https://secwatch.observer/filing/0001628280-24-005913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005913/0001628280-24-005913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005913/ccrn-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:43:00.649009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f37f7f9a0193f07a9c60a5bef4960599dc81d14","claim":"CROSS COUNTRY HEALTHCARE INC reported financial results for full year ended December 31, 2023.","evidence_excerpt":"On February 21, 2024, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the fourth quarter and full year ended December 31, 2023, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005913/0001628280-24-005913-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"f982f4b5b2f836412c32c15eac9c6a5cddea7b75","claim":"CROSS COUNTRY HEALTHCARE INC reported financial results for fourth quarter ended December 31, 2023.","evidence_excerpt":"On February 21, 2024, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the fourth quarter and full year ended December 31, 2023, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000162828024005913/0001628280-24-005913-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}